Showing: 1 - 3 of 3 RESULTS

CDC ensemble forecast forsees death toll from Covid-19 climbing to 233,000 by end of month

A Centers for Disease Control and Prevention forecast that combines the data from dozens of independent models predicts US deaths from Covid-19 could reach 233,000 by the end of the month.



a man in a police car parked in a parking lot: People line up in their vehicles to undergo the coronavirus disease (COVID-19) tests, distributed by the Wisconsin National Guard at the United Migrant Opportunity Services center, as cases spread in the Midwest, in Milwaukee, Wisconsin, U.S., October 2, 2020. REUTERS/Alex Wroblewski


© Alex Wroblewski/Reuters
People line up in their vehicles to undergo the coronavirus disease (COVID-19) tests, distributed by the Wisconsin National Guard at the United Migrant Opportunity Services center, as cases spread in the Midwest, in Milwaukee, Wisconsin, U.S., October 2, 2020. REUTERS/Alex Wroblewski

“This week’s national ensemble forecast indicates an uncertain trend in new COVID-19 deaths reported over the next four weeks and predicts that 2,800 to 6,800 new deaths will likely be reported during the week ending October 31,” the CDC says on its website.

A prior ensemble forecast said there would be a total of 207,000 to 218,000 coronavirus deaths by the end of this week.

More than 212,000 Americans have already lost their lives to the virus, according to Johns Hopkins University.

But deaths in the US have been declining recently. A total of 4,869 people in the US died from Covid-19 during in the first week of October, down 13% when compared to the first week of September (5,611 reported deaths).

New cases on the increase

Covid-19 cases are trending upward across the US, with only two states reporting a decline of cases compared to last week. And hospitalizations across the country have also begun to rise, according to data from the COVID Tracking Project.

Wisconsin health officials reported a record-high number of 141 new patients Wednesday, days after the state saw records in new Covid-19 cases and deaths. Gov. Tony Evers announced the state will open a field hospital in response to the surge in hospitalizations.

“We obviously hoped this day wouldn’t come but, unfortunately, Wisconsin is in a much different and more dire place today, and our health care systems are being overwhelmed,” Evers said.

Other state leaders say they’re not trailing far behind.

“Our hospitalization rates are surging and beginning to place a strain on our healthcare system (especially staffing),” Utah Lt. Gov Spencer Cox wrote on Twitter. “Sadly, we are now seeing increased fatalities. The Wisconsin announcement should be a sobering reminder as Utah isn’t far behind in infection rates.”

Montana, Nebraska, North Dakota, Oklahoma, South Dakota and Wyoming have all seen record-high hospitalization numbers in the past days.

The uptick in Covid-19 patients comes as the US approaches winter with a daily Covid-19 base line that experts say is far too high. For the first time since August, the nation is averaging more than 44,000 new Covid-19 cases daily, according to data from Johns Hopkins University — an average that won’t help as the country enters what health officials say will be a challenging season.

More cases will mean more community spread, more hospitalizations and ultimately, more deaths, Dr. Anthony Fauci has said.

At least half of US states, scattered across the Midwest and Northeast, are reporting more new cases than the previous week, according to Johns

Regenerative Medicine Market Share, Trend, Opportunity, Affect On Demand By COVID-19 Pandemic And Forecast 2020-2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (AmericaNewsHour) —
Regenerative Medicine Market Analysis
According to Verified Market Research, the Global Regenerative Medicine Market was valued at USD 19.10 Billion in 2018 and is expected to witness a growth of 22.72% from 2019-2026 and reach USD 98.10 Billion by 2026.

What is Regenerative Medicine Market?
The field of regenerative medicine comprises of abundant strategies, which mainly includes use of materials and de novo generated cells, as well as various amalgamations thereof, to substitute the lost tissue, efficiently replacing it both anatomically and functionally, or to contribute to tissue restoration. The main objective of regenerative medicine is to propagate replacement tissue or organs for patients who have sustained an injury or have had a disease that permanently damaged their tissue. National Institutes of Health defines regenerative medicine as a process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects.
Regenerative Medicine can be perceived as an interdisciplinary field of research and clinical applications which mainly focuses on the repair, replacement or regeneration of cells, tissues or organs. Regenerative Medicine mainly restores impaired function resulting from any cause. Regenerative medicine has the ability to rectify or substitute tissues and organs impaired by age, disease, or trauma, as well as to normalize congenital defects.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085009

Regenerative Medicine Market Outlook
Over the last decade, stem cell biology has experienced a breakthrough in scientific and technological developments that will together have foremost and continuing influence on regenerative medicine. These entails capability to produce pluripotent stem cells from adult body cells and to cultivate mini-organs from these or from adult stem cells in well-defined culture conditions. Both methodologies offer ways to develop functional cells of human tissue that could be used for transplantation and tissue repair.
Government policies favoring regenerative medicine is one of the major reasons which has been driving the market growth. The European Union (EU) and Dutch government have prioritized regenerative medicine as an area of key strategic relevance. Apart from this, rapid increase in aged population has also boomed the market in North American region. The North Carolina Tissue Engineering and Regenerative Medicine Society is an organization in the U.S. working to improve and advance basic research, commercial development and education in the field of regenerative medicine. In the U.S., two major government agencies – NIH and CIRM – gather funds for academic translational stem cell research and regenerative medicine development. Increasing global healthcare expenditure is also expected to fuel the market.

Lack of awareness and ethical issues regarding the use of Embryonic Stem Cell for R&D is expected to hinder the market for regenerative medicine. The market growth rate is highly influenced by the adoption rate of cell therapy in the market, as it is an integral part of regenerative medicine.

Global Precision Medicine Market 2020 with (COVID-19) Impact Analysis, Product Type, Application, Key Manufacturers, Regions and Forecast to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (CDN Newswire via Comtex) —
A wide-ranging analysis report titled Global Precision Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025 provides a brief overview of the market covering the scope, size, disposition, and growth of the industry. The report presents an estimate of the current market scenario and data related to the competitive landscape of the industry. It delivers five-year industry forecasts, growth rates, and an analysis of the industry key players and their market shares. The report shows information regards to several regions that have successfully established its position in the global Precision Medicine market. The geographical and competitive dynamics of this global market will help you get a comprehensive picture of the market.

An industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and the market forecast is provided. The report gives global Precision Medicine market share analysis, as well as analyzes market position, market share, and segmented revenue. Further company and financial overview, product portfolio, new project launched, recent development analysis are the parameters added with this report.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/8778

The report investigates the development, trends, and new entrants in the sector, with elaborate profiles of the leading companies operating in the market, including: Johnson & Johnson, Novartis, Illumina, IBM, Thermo Fisher Scientific, GE Healthcare, Almac Group, Laboratory Corporation of America Holdings, Roche, Abbott Laboratories, Randox Laboratories, Intel Corporation, Healthcore, Qiagen, Biomrieux Sa, Cepheid

In market segmentation by types, the report covers: Diagnostics, Therapies

In market segmentation by applications, the report covers the following uses: Oncology, Neurosciences, Immunology, Respiratory, Others

The report provides a 5-year forecast (2020-2025) assessed based on how the global Precision Medicine market is predicted to grow in major regions like: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey and South Africa)

Industry Size & Forecast: The report offers estimations on the global Precision Medicine market industry size on the basis of value and volume are provided in this part of the report. This report offers deep insights into the prevailing and upcoming market trends. Then it has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size. Market developments and future opportunities estimated to emerge in the market industry are looked into in this study. The forecasts are provided taking into consideration product, application, and regional segments of the market.

ACCESS FULL REPORT:https://www.marketquest.biz/report/8778/global-precision-medicine-market-2020-by-company-regions-type-and-application-forecast-to-2025

A Peek At Over the Highlights of the Report:

  • The study provides a synopsis